Autor: |
Simin Laiq, Mubarak Al Yaqoobi, Maimuna Al Saadi, Semee Rizvi, Zahra Al Hajri, Saleh Al Azri, Khalsa Al Ramadhani, Qasim Al Hinai |
Jazyk: |
angličtina |
Rok vydání: |
2022 |
Předmět: |
|
Zdroj: |
Clinical Infection in Practice, Vol 13, Iss , Pp 100126- (2022) |
Druh dokumentu: |
article |
ISSN: |
2590-1702 |
DOI: |
10.1016/j.clinpr.2021.100126 |
Popis: |
Phaeohyphomycosis, previously known as chromoblastomycosis, is a chronic mycosis, usually affecting the skin. It is caused by dematiaceous fungi, which are a group of fungi that produce melanin in their cell walls. Cerebral phaeohyphomycosis occurs as a part of invasive presentation of the fungi, which usually affects immunocompromised patients, but may affect immunocompetent individuals as well. Cerebral infection in phaeohyphomycosis is associated with a poor prognosis regardless of the immune status of the patient. COVID-19 SARS-CoV-2 infection and/or medications used for its treatment may compromise the immune system, including in the post-COVID-19 period, resulting in invasive fungal infections, which have frequently been reported recently during the COVID-19 pandemic. We report a case of Fonsecaea associated cerebral phaeohyphomycosis in a recently diagnosed diabetic Omani lady, who presented to our hospital 6 weeks after recovery and discharge from hospitalization for moderate COVID-19 pneumonia. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|